Publications
Detailed Information
Impacts of Vaccination on Hepatitis B Viral Infections in Korea over a 25-Year Period
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Neung Hwa | - |
dc.contributor.author | Chung, Young-Hwa | - |
dc.contributor.author | Lee, Hyo-Suk | - |
dc.date.accessioned | 2012-05-29T07:09:32Z | - |
dc.date.available | 2012-05-29T07:09:32Z | - |
dc.date.issued | 2010 | - |
dc.identifier.citation | INTERVIROLOGY; Vol.53 1; 20-28 | ko_KR |
dc.identifier.issn | 0300-5526 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76562 | - |
dc.description.abstract | Background: Hepatitis B virus (HBV) vaccination has effectively reduced the acute and chronic infection rates in recent years. Since 1983, HBV vaccination has been recommended for all neonates in Korea. Methods: This article reviews the impacts of HBV vaccination throughout the past 25 years in Korea. Before the introduction of the HBV vaccination program, approximately 8% of the general Korean population tested positive for hepatitis B virus surface antigen (HBsAg). Results: The percentage of vaccinated infants has surpassed 98.9% since 1990. The HBsAg carrier rate in the general population decreased to 3.7% in 2007. In particular, the prevalence of HBsAg decreased to 0.44% in teenagers and to 0.2% in children younger than 10 years. In addition, administration of the HBV vaccine may have reduced the risk of hepatocellular carcinoma among adults. Despite the administration of hepatitis B immunoglobulin and the HBV vaccine to children with HBsAg-positive mothers, the failure rate of HBV immunoprophylaxis was 4.2% in 2008. In Korea, there have been no reported cases of HBV surface gene variants such as G145R. Conclusions: The prevalence of HBV carriers in Korea was markedly reduced after the introduction of the universal HBV vaccination program. Korea is now classified as an area of intermediate endemicity for HBV. Copyright (C) 2010 S. Karger AG, Basel | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | KARGER | ko_KR |
dc.subject | Epidemiology | ko_KR |
dc.subject | Hepatitis B vaccine | ko_KR |
dc.subject | Korea | ko_KR |
dc.subject | Hepatitis B virus | ko_KR |
dc.title | Impacts of Vaccination on Hepatitis B Viral Infections in Korea over a 25-Year Period | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 박능화 | - |
dc.contributor.AlternativeAuthor | 정영화 | - |
dc.contributor.AlternativeAuthor | 이효석 | - |
dc.identifier.doi | 10.1159/000252780 | - |
dc.citation.journaltitle | INTERVIROLOGY | - |
dc.description.citedreference | Chen DS, 2009, J HEPATOL, V50, P805, DOI 10.1016/j.jhep.2009.01.002 | - |
dc.description.citedreference | Song EY, 2009, INTERVIROLOGY, V52, P57, DOI 10.1159/000214633 | - |
dc.description.citedreference | KANG JH, 2008, KOREAN J PEDIAT, V51, P1165 | - |
dc.description.citedreference | KIM SR, 2008, ONCOLOGY S1, V75, P13 | - |
dc.description.citedreference | JEONG SH, 2008, KOREAN J GASTROENTER, V51, P331 | - |
dc.description.citedreference | *KOR CENT DIS CONT, 2008, CURR STAT SURV NAT I | - |
dc.description.citedreference | CHOE BH, 2008, KOREAN J PEDIAT, V51, P696 | - |
dc.description.citedreference | *KOR CENT DIS CONT, 2008, COMM DIS MONTHL REP, P14 | - |
dc.description.citedreference | *MIN HLTH WELF FAM, 2008, 2008 GUID HEP B VERT, P6 | - |
dc.description.citedreference | *KOR CENT DIS CONT, 2008, 4 KOR NAT HLTH NUTR, P70 | - |
dc.description.citedreference | Han KH, 2007, HEPATOL RES, V37, pS106, DOI 10.1111/j.1872-034X.2007.00171.x | - |
dc.description.citedreference | Song YM, 2007, EUR J PEDIATR, V166, P813, DOI 10.1007/s00431-006-0327-5 | - |
dc.description.citedreference | *KOR NAT STAT OFF, 2007, ANN STAT REP CAUS DE | - |
dc.description.citedreference | *MIN ED SC TECHN, 2007, 2006 REP SAMPL AN RE, P9 | - |
dc.description.citedreference | *KOR CENT DIS CONT, 2007, 4 KOR NAT HLTH NUTR, P70 | - |
dc.description.citedreference | *KOR NAT STAT OFF, 2006, ANN STAT REP CAUS DE | - |
dc.description.citedreference | AN YW, 2006, KOREAN J PEDIAT, V49, P630 | - |
dc.description.citedreference | Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206 | - |
dc.description.citedreference | Cha C, 2005, BEST PRACT RES CL GA, V19, P25 | - |
dc.description.citedreference | KIM JH, 2005, KOREAN J HEPATOL, V11, P320 | - |
dc.description.citedreference | YIM HJ, 2005, KOREAN J MED, V69, P601 | - |
dc.description.citedreference | KIM B, 2005, KOREAN J OBSTE GYNEC, V48, P2067 | - |
dc.description.citedreference | SEO K, 2005, KOREAN J OBSTET GYNE, V48, P2119 | - |
dc.description.citedreference | Lok ASF, 2004, GASTROENTEROLOGY, V127, pS303, DOI 10.1053/j.gast.2004.09.045 | - |
dc.description.citedreference | Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087 | - |
dc.description.citedreference | *KOR CENT DIS CONT, 2004, REP KOR CDCP, P365 | - |
dc.description.citedreference | Lee DH, 2002, J KOREAN MED SCI, V17, P457 | - |
dc.description.citedreference | Francois G, 2001, VACCINE, V19, P3799, DOI 10.1016/S0264-410X(01)00108-6 | - |
dc.description.citedreference | Lee KM, 2001, J KOREAN MED SCI, V16, P359 | - |
dc.description.citedreference | JANG MK, 2001, KOREAN J INTERN MED, V16, P153 | - |
dc.description.citedreference | KONG H, 2001, KOREAN J HEPATOL, V7, P387 | - |
dc.description.citedreference | CHO HH, 2001, KOREAN J HEPATOL, V7, P439 | - |
dc.description.citedreference | KIM RK, 2000, KOREAN J HEPATOL, V6, P474 | - |
dc.description.citedreference | JANG MK, 2000, KOREAN J MED, V58, P608 | - |
dc.description.citedreference | Ngui SL, 1998, CLIN INFECT DIS, V27, P100 | - |
dc.description.citedreference | Lee MS, 1998, INT J EPIDEMIOL, V27, P316 | - |
dc.description.citedreference | PARK JW, 1998, KOREAN J MED, V55, P176 | - |
dc.description.citedreference | LEE CH, 1998, KOREAN J MED, V55, P715 | - |
dc.description.citedreference | HUH K, 1998, J KOREAN MED SCI, V13, P306 | - |
dc.description.citedreference | Hsu HY, 1997, HEPATOLOGY, V26, P786 | - |
dc.description.citedreference | Chang MH, 1997, NEW ENGL J MED, V336, P1855 | - |
dc.description.citedreference | LEE SY, 1997, KOREAN J PEDIAT INFE, V4, P240 | - |
dc.description.citedreference | SIM JG, 1995, J KOREAN PEDIAT SOC, V38, P1535 | - |
dc.description.citedreference | *KOR I HLTH SOC AF, 1994, NAT FERT FAM HLTH SU | - |
dc.description.citedreference | *WHO, 1992, WKLY EPIDEMIOL REC, V3, P11 | - |
dc.description.citedreference | CHUN BY, 1992, J EPIDEMIOL, V14, P70 | - |
dc.description.citedreference | AHN YO, 1992, SEOUL J MED, V33, P105 | - |
dc.description.citedreference | LIN HH, 1991, VACCINE, V9, P457 | - |
dc.description.citedreference | CARMAN WF, 1990, LANCET, V336, P325 | - |
dc.description.citedreference | LEE HS, 1990, J KOREAN MED SCI, V5, P149 | - |
dc.description.citedreference | OH EA, 1990, KOREAN J GASTROENTER, V22, P825 | - |
dc.description.citedreference | IP HMH, 1989, LANCET, V1, P406 | - |
dc.description.citedreference | PARK BJ, 1989, KOREAN J EPIDEMIOL, V11, P263 | - |
dc.description.citedreference | KIM IS, 1987, KOREAN J EPIDEMIO, V9, P40 | - |
dc.description.citedreference | LEE SD, 1986, HEPATOLOGY, V6, P369 | - |
dc.description.citedreference | KIM SJ, 1986, KOREAN J INTERN MED, V31, P313 | - |
dc.description.citedreference | CHUNG WK, 1985, J INFECT DIS, V151, P280 | - |
dc.description.citedreference | BEASLEY RP, 1983, LANCET, V2, P1099 | - |
dc.description.citedreference | KIM YJ, 1983, KOREAN J MED, V26, P884 | - |
dc.description.citedreference | LEE JJ, 1982, KOR J INT MED, V25, P1191 | - |
dc.description.citedreference | STEVENS CE, 1975, NEW ENGL J MED, V292, P771 | - |
dc.description.citedreference | *WHO, STAT HEP B | - |
dc.description.citedreference | *WHO, VACC BIOL WHO VACC P | - |
dc.description.tc | 9 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.